(X0) 15088259: HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS

(A1) 20160289238: HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS

(B2) 9944647: HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS

HE, CHUNHONG

LI, ZHENWU

WU, LIANGXING

YAO, WENQING

ZHANG, FENGLEI

N/A

INCYTE CORPORATION

38242/1

(X0) 15065409: BICYCLIC AZAHETEROCYCLOBENZYLAMINES AS PI3K INHIBITORS

(A1) 20160264580: BICYCLIC AZAHETEROCYCLOBENZYLAMINES AS PI3K INHIBITORS

(B2) 9944646: BICYCLIC AZAHETEROCYCLOBENZYLAMINES AS PI3K INHIBITORS

INCYTE CORPORATION

N/A

39044/691

(X0) 15016841: IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS

(A1) 20160326178: IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS

(B2) 9944645: IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS

INCYTE CORPORATION

N/A

41865/393

(X0) 15065409: BICYCLIC AZAHETEROCYCLOBENZYLAMINES AS PI3K INHIBITORS

(A1) 20160264580: BICYCLIC AZAHETEROCYCLOBENZYLAMINES AS PI3K INHIBITORS

(B2) 9944646: BICYCLIC AZAHETEROCYCLOBENZYLAMINES AS PI3K INHIBITORS

COMBS, ANDREW P.

SPARKS, RICHARD B.

MADUSKUIE, THOMAS P.

N/A

INCYTE CORPORATION

39044/610

(X0) 15712850: PROCESSES OF PREPARING A JAK1 INHIBITOR AND NEW FORMS THERETO

(A1) 20180099978: PROCESSES OF PREPARING A JAK1 INHIBITOR AND NEW FORMS THERETO

ZHOU, JIACHENG

LIU, PINGLI

CHEN, SHILI

WU, YONGZHONG

WANG, DENGJIN

JIA, ZHONGJIANG

QIAO, LEI

FRIETZE, WILLIAM

XIA, MICHAEL

DAI, YINGRUI

INCYTE CORPORATION

43776/63

(X0) 15398907: TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

(A1) 20170210754: TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

(B2) 9938294: TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

INCYTE CORPORATION

N/A

42240/496

(X0) 15398907: TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

(A1) 20170210754: TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

(B2) 9938294: TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

COMBS, ANDREW P.

SPARKS, RICHARD B.

MADUSKUIE, THOMAS P.

RODGERS, JAMES D.

N/A

INCYTE CORPORATION

42240/449

(X0) 14193481: USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS

(A1) 20140249132: USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS

(B2) 9932341: USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS

LI, YUN-LONG

YAO, WENQING

COMBS, ANDREW P.

YUE, EDDY W.

MEI, SONG

ZHU, WENYU

GLENN, JOSEPH

MADUSKUIE, THOMAS P., JR.

SPARKS, RICHARD B.

DOUTY, BRENT

HE, CHUNHONG

N/A

INCYTE CORPORATION

33407/492

8716303: N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-D]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-D]PYRIMIDINES AS JANUS KINASE INHIBITORS

9334274: N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS

9249145: HETEROCYCLIC DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS

8765734: PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS

9464088: PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS

8933085: CYCLOBUTYL SUBSTITUTED PYRROLOPYRIDINE AND PYRROLOPYRIMIDINE DERIVATIVES AS JAK INHIBITORS

9034884: HETEROCYCLIC-SUBSTITUTED PYRROLOPYRIDINES AND PYRROLOPYRIMIDINES AS JAK INHIBITORS

8691807: AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS

9023840: AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS

9487521: PROCESSES AND INTERMEDIATES FOR MAKING A JAK INHIBITOR

9359358: CYCLOHEXYL AZETIDINE DERIVATIVES AS JAK INHIBITORS

8987443: PROCESSES AND INTERMEDIATES FOR MAKING A JAK INHIBITOR

9193733: PIPERIDINYLCYCLOBUTYL SUBSTITUTED PYRROLOPYRIDINE AND PYRROLOPYRIMIDINE DERIVATIVES AS JAK INHIBITORS

9181271: TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS

7335667: PYRROLO[2,3-B]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-B]PYRIMIDIN-4-YL-AMINES AS JANUS KINASE INHIBITORS

8053433: PYRROLO[2,3-B]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-B]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS

8445488: PYRROLO[2,3-B]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-B]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS

8741895: PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS

9090611: PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS

8563541: AZEPINE INHIBITORS OF JANUS KINASES

8835423: AZEPINE INHIBITORS OF JANUS KINASES

7598257: HETEROARYL SUBSTITUTED PYRROLO[2,3-B]PYRIDINES AND PYRROLO[2,3-B]PYRIMIDINES AS JANUS KINASE INHIBITORS

8541425: HETEROARYL SUBSTITUTED PYRROLO[2,3-B]PYRIDINES AND PYRROLO[2,3-B]PYRIMIDINES AS JANUS KINASE INHIBITORS

8946245: HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS

8530485: HETEROARYL SUBSTITUTED PYRROLO[2,3-B]PYRIDINES AND PYRROLO[2,3-B]PYRIMIDINES AS JANUS KINASE INHIBITORS

9206187: Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors

8933086: Heteroaryl Substituted Pyrrolo[2,3-B]Pyridines And Pyrrolo[2,3-B]Pyrimidines As Janus Kinase Inhibitors

9079912: Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors

8415362: PYRAZOLYL SUBSTITUTED PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS

8513270: SUBSTITUTED HETEROCYCLES AS JANUS KINASE INHIBITORS

8841318: SUBSTITUTED HETEROCYCLES AS JANUS KINASE INHIBITORS

7834022: METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

8889697: METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

8722693: SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

8822481: SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

8829013: SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

9376439: SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

8309718: 4-PYRAZOLYL-N-ARYLPYRIMIDIN-2-AMINES AND 4-PYRAZOLYL-N-HETEROARYLPYRIMIDIN-2-AMINES AS JANUS KINASE INHIBITORS

8158616: AZETIDINE AND CYCLOBUTANE DERIVATIVES AS JAK INHIBITORS

8420629: AZETIDINE AND CYCLOBUTANE DERIVATIVES AS JAK INHIBITORS

8410265: PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS

9000161: PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS

8883806: PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS

8993582: PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS

8604043: 3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL]OCTANE- OR HEPTANE-NITRILE AS JAK INHIBITORS

9216984: 3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL]OCTANE- OR HEPTANE-NITRILE AS JAK INHIBITORS

8486902: HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-D] PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

8748401: HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

9512161: HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

8940752: PYRIMIDINONES AS PI3K INHIBITORS

9434746: PYRIMIDINONES AS PI3K INHIBITORS

8759359: SUBSTITUTED HETEROARYL FUSED DERIVATIVES AS PI3K INHIBITORS

9403847: SUBSTITUTED HETEROARYL FUSED DERIVATIVES AS PI3K INHIBITORS

8680108: SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS

9062055: FUSED PYRROLE DERIVATIVES AS PI3K INHIBITORS

9193721: FUSED DERIVATIVES AS PI3KDELTA INHIBITORS

9096600: N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS

9108984: SUBSTITUTED DIAMINO-PYRIMIDINE AND DIAMINO-PYRIDINE DERIVATIVES AS PI3K INHIBITORS

9126948: PYRIMIDINE-4,6-DIAMINE DERIVATIVES AS PI3K INHIBITORS

9199982: HETEROCYCLYLAMINES AS PI3K INHIBITORS

9309251: BICYCLIC AZAHETEROCYCLOBENZYLAMINES AS PI3K INHIBITORS

9932341: USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS

INCYTE CORPORATION

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

INCYTE HOLDINGS CORPORATION AND INCYTE CORPORATION

35924/4

8716303: N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-D]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-D]PYRIMIDINES AS JANUS KINASE INHIBITORS

9334274: N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS

9249145: HETEROCYCLIC DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS

8765734: PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS

9464088: PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS

8933085: CYCLOBUTYL SUBSTITUTED PYRROLOPYRIDINE AND PYRROLOPYRIMIDINE DERIVATIVES AS JAK INHIBITORS

9034884: HETEROCYCLIC-SUBSTITUTED PYRROLOPYRIDINES AND PYRROLOPYRIMIDINES AS JAK INHIBITORS

8691807: AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS

9023840: AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS

9487521: PROCESSES AND INTERMEDIATES FOR MAKING A JAK INHIBITOR

9359358: CYCLOHEXYL AZETIDINE DERIVATIVES AS JAK INHIBITORS

8987443: PROCESSES AND INTERMEDIATES FOR MAKING A JAK INHIBITOR

9193733: PIPERIDINYLCYCLOBUTYL SUBSTITUTED PYRROLOPYRIDINE AND PYRROLOPYRIMIDINE DERIVATIVES AS JAK INHIBITORS

9181271: TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS

7335667: PYRROLO[2,3-B]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-B]PYRIMIDIN-4-YL-AMINES AS JANUS KINASE INHIBITORS

8053433: PYRROLO[2,3-B]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-B]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS

8445488: PYRROLO[2,3-B]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-B]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS

8741895: PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS

9090611: PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS

8563541: AZEPINE INHIBITORS OF JANUS KINASES

8835423: AZEPINE INHIBITORS OF JANUS KINASES

7598257: HETEROARYL SUBSTITUTED PYRROLO[2,3-B]PYRIDINES AND PYRROLO[2,3-B]PYRIMIDINES AS JANUS KINASE INHIBITORS

8541425: HETEROARYL SUBSTITUTED PYRROLO[2,3-B]PYRIDINES AND PYRROLO[2,3-B]PYRIMIDINES AS JANUS KINASE INHIBITORS

8946245: HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS

8530485: HETEROARYL SUBSTITUTED PYRROLO[2,3-B]PYRIDINES AND PYRROLO[2,3-B]PYRIMIDINES AS JANUS KINASE INHIBITORS

9206187: Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors

8933086: Heteroaryl Substituted Pyrrolo[2,3-B]Pyridines And Pyrrolo[2,3-B]Pyrimidines As Janus Kinase Inhibitors

9079912: Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors

8415362: PYRAZOLYL SUBSTITUTED PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS

8513270: SUBSTITUTED HETEROCYCLES AS JANUS KINASE INHIBITORS

8841318: SUBSTITUTED HETEROCYCLES AS JANUS KINASE INHIBITORS

7834022: METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

8889697: METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

8722693: SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

8822481: SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

8829013: SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

9376439: SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

8309718: 4-PYRAZOLYL-N-ARYLPYRIMIDIN-2-AMINES AND 4-PYRAZOLYL-N-HETEROARYLPYRIMIDIN-2-AMINES AS JANUS KINASE INHIBITORS

8158616: AZETIDINE AND CYCLOBUTANE DERIVATIVES AS JAK INHIBITORS

8420629: AZETIDINE AND CYCLOBUTANE DERIVATIVES AS JAK INHIBITORS

8410265: PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS

9000161: PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS

8883806: PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS

8993582: PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS

8604043: 3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL]OCTANE- OR HEPTANE-NITRILE AS JAK INHIBITORS

9216984: 3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL]OCTANE- OR HEPTANE-NITRILE AS JAK INHIBITORS

8486902: HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-D] PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

8748401: HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

9512161: HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

8940752: PYRIMIDINONES AS PI3K INHIBITORS

9434746: PYRIMIDINONES AS PI3K INHIBITORS

8759359: SUBSTITUTED HETEROARYL FUSED DERIVATIVES AS PI3K INHIBITORS

9403847: SUBSTITUTED HETEROARYL FUSED DERIVATIVES AS PI3K INHIBITORS

8680108: SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS

9062055: FUSED PYRROLE DERIVATIVES AS PI3K INHIBITORS

9193721: FUSED DERIVATIVES AS PI3KDELTA INHIBITORS

9096600: N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS

9108984: SUBSTITUTED DIAMINO-PYRIMIDINE AND DIAMINO-PYRIDINE DERIVATIVES AS PI3K INHIBITORS

9126948: PYRIMIDINE-4,6-DIAMINE DERIVATIVES AS PI3K INHIBITORS

9199982: HETEROCYCLYLAMINES AS PI3K INHIBITORS

9309251: BICYCLIC AZAHETEROCYCLOBENZYLAMINES AS PI3K INHIBITORS

9932341: USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS

INCYTE CORPORATION

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

36054/696

(X0) 15281679: HETEROCYCLIC COMPOUNDS USEFUL AS PIM KINASE INHIBITORS

(A1) 20170096411: HETEROCYCLIC COMPOUNDS USEFUL AS PIM KINASE INHIBITORS

(B2) 9920032: HETEROCYCLIC COMPOUNDS USEFUL AS PIM KINASE INHIBITORS

VECHORKIN, OLEG

LI, YUN-LONG

SOKOLSKY, ALEXANDER

WANG, ANLAI

ZHU, WENYU

ZHUO, JINCONG

N/A

INCYTE CORPORATION

41535/918

(X0) 15186697: SUBSTITUTED PYRROLO[2,3-c]PYRIDINES AND PYRAZOLO[3,4-c]PYRIDINES AS BET PROTEIN INHIBITORS

(A1) 20170014418: SUBSTITUTED PYRROLO[2,3-c]PYRIDINES AND PYRAZOLO[3,4-c]PYRIDINES AS BET PROTEIN INHIBITORS

(B2) 9918990: SUBSTITUTED PYRROLO[2,3-c]PYRIDINES AND PYRAZOLO[3,4-c]PYRIDINES AS BET PROTEIN INHIBITORS

YUE, EDDY W.

COMBS, ANDREW P.

DOUTY, BRENT

N/A

INCYTE CORPORATION

39056/348

(X0) 15698771: PYRAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF

(A1) 20180072741: PYRAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF

VECHORKIN, OLEG

LIU, KAI

PAN, JUN

SOKOLSKY, ALEXANDER

YE, HAI FEN

YE, QINDA

YAO, WENQING

HUMMEL, JOSHUA

INCYTE CORPORATION

43833/84

(X0) 15698753: PYRAZOLOPYRIDINE COMPOUNDS AND USES THEREOF

(A1) 20180072718: PYRAZOLOPYRIDINE COMPOUNDS AND USES THEREOF

LIU, KAI

PAN, JUN

SOKOLSKY, ALEXANDER

VECHORKIN, OLEG

YE, HAI FEN

YE, QINDA

YAO, WENQING

INCYTE CORPORATION

43849/207

(X0) 15698788: PYRAZOLOPYRIDINE COMPOUNDS AND USES THEREOF

(A1) 20180072720: PYRAZOLOPYRIDINE COMPOUNDS AND USES THEREOF

VECHORKIN, OLEG

PAN, JUN

LIU, KAI

SOKOLSKY, ALEXANDER

WANG, ANLAI

YE, HAI FEN

YE, QINDA

YAO, WENQING

INCYTE CORPORATION

43833/159

(X0) 15698768: PYRAZOLOPYRIDONE COMPOUNDS AND USES THEREOF

(A1) 20180072719: PYRAZOLOPYRIDONE COMPOUNDS AND USES THEREOF

YE, QINDA

LIU, KAI

PAN, JUN

SOKOLSKY, ALEXANDER

VECHORKIN, OLEG

YAO, WENQING

INCYTE CORPORATION

44159/721

(X0) 14873078: TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS

(A1) 20160024109: TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS

(B2) 9908895: TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS

LI, YUN-LONG

ZHU, WENYU

MEI, SONG

GLENN, JOSEPH

N/A

INCYTE CORPORATION

36823/519

(X0) 14873078: TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS

(A1) 20160024109: TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS

(B2) 9908895: TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS

INCYTE CORPORATION

N/A

36823/593

(X0) 15687697: HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

(A1) 20180057486: HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

WU, LIANGXING

ZHANG, FENGLEI

MEI, SONG

YAO, WENQING

INCYTE CORPORATION

43803/200

(X0) 15047876: BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS

(A1) 20160244448: BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS

(B2) 9890156: BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS

LU, LIANG

WU, LIANGXING

QIAN, DING-QUAN

YAO, WENQING

N/A

INCYTE CORPORATION

38205/214

(X0) 15405742: BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS

(A1) 20170253587: BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS

(B2) 9890162: BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS

SUN, YAPING

FENG, HAO

LI, YUN-LONG

MEI, SONG

PAN, JUN

WANG, ANLAI

YE, HAI-FEN

ZHANG, KE

N/A

INCYTE CORPORATION

42236/239

(X0) 15496824: METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

(A1) 20170326144: METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

INCYTE CORPORATION

44856/942

(X0) 15496824: METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

(A1) 20170326144: METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

RODGERS, JAMES D.

ARVANITIS, ARGYRIOS G.

SHI, JACK GUOEN

SHEPARD, STACEY

INCYTE CORPORATION

44856/480

(X0) 15670094: TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES AS LSD1 INHIBITORS

(A1) 20170362245: TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES AS LSD1 INHIBITORS

WU, LIANGXING

SUN, YAPING

WANG, XIAOZHAO

YAO, WENQING

ZHANG, COLIN

INCYTE CORPORATION

44812/817

(X0) 15632986: MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF USING THE SAME

(A1) 20180030006: MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF USING THE SAME

COMBS, ANDREW P.

YUE, EDDY W.

INCYTE CORPORATION

43172/738

(X0) 15409085: PYRROLO[2,3-B]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-B]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS

(A1) 20170349579: PYRROLO[2,3-B]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-B]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS

(B2) 9879010: PYRROLO[2,3-B]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-B]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS

RODGERS, JAMES D.

WANG, HAISHENG

COMBS, ANDREW P.

SPARKS, RICHARD B.

N/A

INCYTE CORPORATION

41093/116

(X0) 15409085: PYRROLO[2,3-B]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-B]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS

(A1) 20170349579: PYRROLO[2,3-B]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-B]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS

(B2) 9879010: PYRROLO[2,3-B]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-B]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS

INCYTE CORPORATION

N/A

41093/158

(X0) 15093486: PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR

(A1) 20160221996: PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR

(B2) 9873688: PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR

TAO, MING

FRIETZE, WILLIAM

MELONI, DAVID J.

WENG, LINGKAI

ZHOU, JIACHENG

PAN, YONGCHUN

N/A

INCYTE CORPORATION

39044/259

(X0) 15093486: PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR

(A1) 20160221996: PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR

(B2) 9873688: PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR

INCYTE CORPORATION

N/A

39044/308

(X0) 15178838: Spirocycles as Inhibitors of 11-beta Hydroxyl Steroid Dehydrogenase Type 1

(A1) 20160280708: Spirocycles as Inhibitors of 11-beta Hydroxyl Steroid Dehydrogenase Type 1

(B2) 9873698: Spirocycles as Inhibitors of 11-beta Hydroxyl Steroid Dehydrogenase Type 1

INCYTE CORPORATION

N/A

38878/858

(X0) 15178838: Spirocycles as Inhibitors of 11-beta Hydroxyl Steroid Dehydrogenase Type 1

(A1) 20160280708: Spirocycles as Inhibitors of 11-beta Hydroxyl Steroid Dehydrogenase Type 1

(B2) 9873698: Spirocycles as Inhibitors of 11-beta Hydroxyl Steroid Dehydrogenase Type 1

YAO, WENQING

ZHUO, JINCONG

ZHANG, COLIN

N/A

INCYTE CORPORATION

38878/719

(X0) 15649114: HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

(A1) 20180016260: HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

YU, ZHIYONG

WU, LIANGXING

YAO, WENQING

INCYTE CORPORATION

43219/805

(X0) 15624850: BICYCLIC FUSED PYRIMIDINE COMPOUNDS AS TAM INHIBITORS

(A1) 20180009815: BICYCLIC FUSED PYRIMIDINE COMPOUNDS AS TAM INHIBITORS

LI, YUN-LONG

BURNS, DAVID M.

INCYTE CORPORATION

43215/987

(X0) 15631417: HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS

(A1) 20180009816: HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS

BUESKING, ANDREW W.

SPARKS, RICHARD B.

COMBS, ANDREW P.

DOUTY, BRENT

FALAHATPISHEH, NIKOO

SHAO, LIXIN

SHEPARD, STACEY

YUE, EDDY W.

INCYTE CORPORATION

43046/606

(X0) 15712290: BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS

(A1) 20180008610: BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS

LU, LIANG

WU, LIANGXING

SHEN, BO

YAO, WENQING

INCYTE CORPORATION

43796/208

(X0) 15688313: TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

(A1) 20180002334: TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

RODGERS, JAMES D.

SHEPARD, STACEY

WANG, HAISHENG

SHAO, LIXIN

INCYTE CORPORATION

43432/406

(X0) 15613379: TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES AS LSD1 INHIBITORS

(A1) 20170369488: TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES AS LSD1 INHIBITORS

WU, LIANGXING

WANG, XIAOZHAO

YAO, WENQING

ZHANG, COLIN

INCYTE CORPORATION

42626/246

(X0) 15613361: IMIDAZOPYRAZINES AS LSD1 INHIBITORS

(A1) 20170369497: IMIDAZOPYRAZINES AS LSD1 INHIBITORS

WU, LIANGXING

COURTER, JOEL R.

HE, CHUNHONG

LI, JINGWEI

LU, LIANG

SUN, YAPING

WANG, XIAOZHAO

YAO, WENQING

ZHANG, COLIN

ZHUO, JINCONG

INCYTE CORPORATION

42627/861

(X0) 15610015: IMIDAZOPYRIDINES AND IMIDAZOPYRAZINES AS LSD1 INHIBITORS

(A1) 20170369487: IMIDAZOPYRIDINES AND IMIDAZOPYRAZINES AS LSD1 INHIBITORS

WU, LIANGXING

KONKOL, LEAH C.

LAJKIEWICZ, NEIL

LU, LIANG

XU, MEIZHONG

YAO, WENQING

YU, ZHIYONG

ZHANG, COLIN

HE, CHUNHONG

INCYTE CORPORATION

43219/635

(X0) 15357536: TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

(A1) 20170217985: TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

(B2) 9850257: TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

COMBS, ANDREW P.

YUE, EDDY W.

SPARKS, RICHARD B.

MADUSKUIE, THOMAS P.

N/A

INCYTE CORPORATION

40454/788

(X0) 15357536: TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

(A1) 20170217985: TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

(B2) 9850257: TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

INCYTE CORPORATION

N/A

40454/879

(X0) 15626496: HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

(A1) 20170362253: HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

XIAO, KAIJIONG

ZHANG, FENGLEI

WU, LIANGXING

YAO, WENQING

INCYTE CORPORATION

43046/720

(X0) 15626539: CRYSTALLINE SOLID FORMS OF A BET INHIBITOR

(A1) 20170362229: CRYSTALLINE SOLID FORMS OF A BET INHIBITOR

CHEN, SHILI

JIA, ZHONGJIANG

LIU, PINGLI

QIAO, LEI

WU, YONGZHONG

ZHOU, JIACHENG

INCYTE CORPORATION

43152/763

(X0) 15626539: CRYSTALLINE SOLID FORMS OF A BET INHIBITOR

(A1) 20170362229: CRYSTALLINE SOLID FORMS OF A BET INHIBITOR

WILMINGTON PHARMATECH

INCYTE CORPORATION

43152/955

(X0) 15497887: CYCLOPROPYLAMINES AS LSD1 INHIBITORS

(A1) 20170342070: CYCLOPROPYLAMINES AS LSD1 INHIBITORS

WU, LIANGXING

COURTER, JOEL R.

HE, CHUNHONG

QIAN, DING-QUAN

SHEN, BO

WANG, XIAOZHAO

YAO, WENQING

ZHANG, FENGLEI

INCYTE CORPORATION

42251/227

(X0) 15603744: HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

(A1) 20170342060: HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

LU, LIANG

QIAN, DING-QUAN

WU, LIANGXING

YAO, WENQING

INCYTE CORPORATION

43047/5

(X0) 15673529: HETEROCYCLYLAMINES AS PI3K INHIBITORS

(A1) 20170340641: HETEROCYCLYLAMINES AS PI3K INHIBITORS

LI, YUN-LONG

YAO, WENQING

COMBS, ANDREW P.

YUE, EDDY W.

MEI, SONG

ZHU, WENYU

GLENN, JOSEPH

MADUSKUIE, THOMAS P.

SPARKS, RICHARD B.

DOUTY, BRENT

HE, CHUNHONG

INCYTE CORPORATION

43509/702

(X0) 15673529: HETEROCYCLYLAMINES AS PI3K INHIBITORS

(A1) 20170340641: HETEROCYCLYLAMINES AS PI3K INHIBITORS

INCYTE CORPORATION

43509/775

(X0) 15602693: Amido Compounds And Their Use As Pharmaceuticals

(A1) 20170334847: Amido Compounds And Their Use As Pharmaceuticals

YAO, WENQING

ZHUO, JINCONG

XU, MEIZHONG

ZHANG, COLIN

METCALF, BRIAN W.

HE, CHUNHONG

QIAN, DING-QUAN

INCYTE CORPORATION

42562/731

(X0) 15602693: Amido Compounds And Their Use As Pharmaceuticals

(A1) 20170334847: Amido Compounds And Their Use As Pharmaceuticals

INCYTE CORPORATION

42810/499